Increased NOS2 predicts poor survival in estrogen receptor-negative breast cancer patients.
Glynn SA, Boersma BJ, Dorsey TH, Yi M, Yfantis HG, Ridnour LA, Martin DN, Switzer CH, Hudson RS, Wink DA, Lee DH, Stephens RM, Ambs S.
Glynn SA, et al. Among authors: boersma bj.
J Clin Invest. 2010 Nov;120(11):3843-54. doi: 10.1172/JCI42059. Epub 2010 Oct 18.
J Clin Invest. 2010.
PMID: 20978357
Free PMC article.